Dendritic cells stimulate the expansion of BCR-ABL specific CD8(+) T cells with cytotoxic activity against leukaemic cells from patients with chronic myeloid leukemia.

被引:0
|
作者
Nicol, A
Nieda, M
Kikuchi, A
Ishikawa, Y
Taylor, K
Gill, D
Durrant, S
Tadokoro, K
Juji, T
机构
[1] ROYAL BRISBANE HOSP,DEPT HAEMATOL,BRISBANE,QLD 4029,AUSTRALIA
[2] JAPANESE RED CROSS,CENT BLOOD CTR,TOKYO,JAPAN
[3] MATER HOSP,DEPT HAEMATOL,BRISBANE,QLD,AUSTRALIA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:875 / 875
页数:2
相关论文
共 50 条
  • [21] Inducible chronic phase of myeloid leukemia with expansion of hematopoietic stem cells in a transgenic model of BCR-ABL leukemogenesis
    Koschmieder, S
    Göttgens, B
    Zhang, P
    Iwasaki-Arai, J
    Akashi, K
    Kutok, JL
    Dayaram, T
    Geary, K
    Green, AR
    Tenen, DG
    Huettner, CS
    BLOOD, 2005, 105 (01) : 324 - 334
  • [22] Cytotoxic T cell response against 210 kDA chimeric protein coded by the BCR-ABL fusion gene in chronic myeloid leukemia.
    LangladeDemoyen, P
    Abastado, JP
    Even, J
    Gourru, G
    Leblond, V
    Binet, JL
    Kourilsky, P
    BLOOD, 1995, 86 (10) : 2089 - 2089
  • [23] Activated naive γδ T cells accelerate deep molecular response to BCR-ABL inhibitors in patients with chronic myeloid leukemia
    Chang, Yu-Cheng
    Chiang, Yi-Hao
    Hsu, Kate
    Chuang, Chih-Kuang
    Kao, Chen-Wei
    Chang, Yi-Fang
    Chang, Ming-Chih
    Lim, Ken-Hong
    Cheng, Hung-, I
    Hsu, Yen-Ning
    Chen, Caleb G.
    BLOOD CANCER JOURNAL, 2021, 11 (11)
  • [24] Mesenchymal stem cells in patients with chronic myeloid leukemia do not harbor bcr-abl translocation t(9;22).
    Brendel, C
    Rieder, H
    Jänike, M
    Boudriot, U
    Burchert, A
    Reckzeh, B
    BLOOD, 2001, 98 (11) : 145A - 145A
  • [25] BCR-ABL expression in different subpopulations of functionally characterized Ph(+) CD34(+) cells from patients with chronic myeloid leukemia
    MaguerSatta, V
    Petzer, AL
    Eaves, AC
    Eaves, CJ
    BLOOD, 1996, 88 (05) : 1796 - 1804
  • [26] Instability of BCR-ABL gene in primary and cultured chronic myeloid leukemia stem cells
    Jiang, Xiaoyan
    Saw, Kyi Min
    Eaves, Allen
    Eaves, Connie
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (09) : 680 - 693
  • [27] BCR-ABL activity is critical for the immunogenicity of chronic myelogenous leukemia cells.
    Brauer, Katharina M.
    Werth, Daniela
    von Schwarzenberg, Karin
    Bringmann, Anita
    Kanz, Lothar
    Gruenebach, Frank
    Brossart, Peter
    BLOOD, 2006, 108 (11) : 624A - 625A
  • [28] Generation of BCR/ABL positive dendritic cells from chronic myelogenous leukemia CD34+ cells.
    Carlo-Stella, C
    Garau, D
    Regazzi, E
    Sammarelli, G
    Savoldo, B
    Mattioli, P
    Cilloni, D
    Rizzoli, V
    Tabilio, A
    BLOOD, 1998, 92 (10) : 628A - 628A
  • [29] Bcr/Abl translocation status and T cells stimulation capacity of dendritic cells derived from CD34+ and CD34- bone marrow compartments from patients with chronic myeloid leukemia
    Gaafar, A.
    Al-omar, H. M.
    Al-Mokhlafi, Z.
    Al-Sulaiman, A.
    Iqniebi, A.
    Tabakhi, A.
    Al-Hussein, K.
    EXPERIMENTAL HEMATOLOGY, 2007, 35 (09) : 71 - 71
  • [30] Activated naïve γδ T cells accelerate deep molecular response to BCR-ABL inhibitors in patients with chronic myeloid leukemia
    Yu-Cheng Chang
    Yi-Hao Chiang
    Kate Hsu
    Chih-Kuang Chuang
    Chen-Wei Kao
    Yi-Fang Chang
    Ming-Chih Chang
    Ken-Hong Lim
    Hung-I Cheng
    Yen-Ning Hsu
    Caleb G. Chen
    Blood Cancer Journal, 11